公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
1992 | Late survival of non-small cell lung cancer patients with brain metastases: Influence of treatment | Chang D.-B.; PAN-CHYR YANG ; KWEN-TAY LUH ; Kuo S.-H.; RUEY-LONG HONG ; LI-NA LEE | Chest | 61 | 44 | |
1993 | Lymphoblast colony-culture assay in acute lymphoblastic leukemia: A quantitative approach | RUEY-LONG HONG ; Shen S.-W.; Lin M.-T.; HWEI-FANG TIEN ; CHIH-HSIN YANG ; YAO-CHANG CHEN | Leukemia Research | 3 | 1 | |
2022 | Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients | Blanchard P.; Lee A.W.M.; Carmel A.; Wai Tong N.; Ma J.; Chan A.T.C.; Hong R.L.; Chen M.-Y.; Chen L.; Li W.-F.; Huang P.-Y.; Kwong D.L.W.; Poh S.S.X.; Ngan R.; Mai H.-Q.; Ollivier C.; Fountzilas G.; Zhang L.; Bourhis J.; Aupérin A.; Lacas B.; Pignon J.-P.; Benhamou E.; Chakrabandhu S.; TC Chan A.; Chen Q.-Y.; Chen Y.; Chappell R.J.; Choi H.; TT Chua D.; Lee Kiang Chua M.; Higgins J.; Hong M.-H.; RUEY-LONG HONG ; Pun Hui E.; Hsiao C.F.; Kam M.; Angeliki Koliou G.; LW Kwong D.; Lai S.-C.; On Lam K.; LeBlanc M.L.; WM Lee A.; Fun Victor Lee H.; Fei Li W.; Ma B.; Mo F.; Moon J.; Tong Ng W.; O'Sullivan B.; Petit C.; Pierre Pignon J.; Poh S.X.; Rücker G.; Sham J.; Lim Soong Y.; Sun Y.; Tan T.; Tang L.-Q.; Tung Y.; Wee J.; Wu X.; Xu T.; Zhang Y.; Zhu G.; on behalf of the MAC-NPC collaborative Group | Clinical and Translational Radiation Oncology | 17 | 18 | |
2005 | Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma | Chan A.T.C.; Hsu M.-M.; Goh B.C.; Hui E.P.; Liu T.-W.; Millward M.J.; RUEY-LONG HONG ; Whang-Peng J.; Ma B.B.Y.; To K.F.; Mueser M.; Amellal N.; Lin X.; Chang A.Y. | Journal of Clinical Oncology | 261 | 217 | |
1997 | MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer | CHIUN HSU ; KUN-HUEI YEH ; RUEY-LONG HONG ; CHIH-HSIN YANG ; Lin M.-T.; YAO-CHANG CHEN ; ANN-LII CHENG | Journal of the Formosan Medical Association | 4 | 3 | |
2009 | Nasion swelling as the presenting symptom of lung adenocarcinoma | CHUN-TA HUANG ; RUEY-LONG HONG | Journal of Thoracic Oncology | 9 | 9 | |
2015 | Nasopharyngeal Carcinoma and Pulmonary Lymphoepithelioma-like Carcinoma-Metastases or Synchronous Second Primary Cancer | MING-KAI CHUANG ; RUEY-LONG HONG | Journal of Cancer Research and Practice | 0 | 0 | |
2012 | Osteoradionecrosis of the upper cervical spine after radiation therapy for head and neck cancer: Differentiation from recurrent or metastatic disease with MR imaging | Wu L.-A.; HON-MAN LIU ; CHUN-WEI WANG ; YA-FANG CHEN ; RUEY-LONG HONG ; JENG-YUH KO | Radiology | 22 | 20 | |
1998 | Overexpression of p53 predicts shorter survival in diffuse type gastric cancer | WEN-JENG LEE ; CHIA-TUNG SHUN ; RUEY-LONG HONG ; MING-SHIANG WU ; KING-JEN CHANG ; Chen K.-M. | British Journal of Surgery | 19 | 19 | |
2000 | Pegylated liposomal doxorubicin in treating a case of advanced hepatocellular carcinoma with severe hepatic dysfunction and pharmacokinetic study | RUEY-LONG HONG ; Tseng Y.-L.; FU-HSIUNG CHANG | Annals of Oncology | 22 | 19 | |
2022 | Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048 | Rischin D.; Harrington K.J.; Greil R.; Soulières D.; Tahara M.; de Castro Jr G.; Psyrri A.; Braña I.; Neupane P.; Bratland Å.; Fuereder T.; Hughes B.G.M.; Mesía R.; Ngamphaiboon N.; Rordorf T.; Ishak W.Z.W.; RUEY-LONG HONG ; Mendoza R.G.; Jia L.; Chirovsky D.; Norquist J.; Jin F.; Burtness B. | Oral Oncology | 14 | 10 | |
2019 | Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study | Burtness B.; Harrington K.J.; Greil R.; Souli?res D.; Tahara M.; de Castro G.; Jr, Psyrri A.; Bast? N.; Neupane P.; Bratland ?.; Fuereder T.; Hughes B.G.M.; Mes?a R.; Ngamphaiboon N.; Rordorf T.; Wan Ishak W.Z.; RUEY-LONG HONG ; Gonz?lez Mendoza R.; Roy A.; Zhang Y.; Gumuscu B.; Cheng J.D.; Jin F.; Rischin D.; Lerzo G.; Tatangelo M.; Varela M.; Zarba J.J.; Boyer M.; Gan H.; Gao B.; Hughes B.; Mallesara G.; Taylor A.; Burian M.; Barrios C.H.; de Castro Junior D.O.; Castro G.; Franke F.A.; Girotto G.; Lima I.P.F.; Nicolau U.R.; Pinto G.D.J.; Santos L.; Victorino A.-P.; Chua N.; Couture F.; Gregg R.; Hansen A.; Hilton J.; McCarthy J.; Soulieres D.; Ascui R.; Gonzalez P.; Villanueva L.; Torregroza M.; Zambrano A.; Holeckova P.; Kral Z.; Melichar B.; Prausova J.; Vosmik M.; Andersen M.; Gyldenkerne N.; Jurgens H.; Putnik K.; Reinikainen P.; Gruenwald V.; Laban S.; Aravantinos G.; Boukovinas I.; Georgoulias V.; Kwong D.; Al-Farhat Y.; Csoszi T.; Erfan J.; Horvai G.; Landherr L.; Remenar E.; Ruzsa A.; Szota J.; Billan S.; Gluck I.; Gutfeld O.; Popovtzer A.; Benasso M.; Bui S.; Ferrari V.; Licitra L.; Nole F.; Fujii T.; Fujimoto Y.; Hanai N.; Hara H.; Matsumoto K.; Mitsugi K.; Monden N.; Nakayama M.; Okami K.; Oridate N.; Shiga K.; Shimizu Y.; Sugasawa M.; Takahashi M.; Takahashi S.; Tanaka K.; Ueda T.; Yamaguchi H.; Yamazaki T.; Yasumatsu R.; Yokota T.; Yoshizaki T.; Kudaba I.; Stara Z.; Cheah S.K.; Aguilar Ponce J.; Gonzalez Mendoza R.; Hernandez Hernandez C.; Medina Soto F.; Buter J.; Hoeben A.; Oosting S.; Suijkerbuijk K.; Bratland A.; Brydoey M.; Alvarez R.; Mas L.; Caguioa P.; Querol J.; Regala E.E.; Tamayo M.B.; Villegas E.M.; Kawecki A.; Karpenko A.; Klochikhin A.; Smolin A.; Zarubenkov O.; Goh B.C.; Cohen G.; du Toit J.; Jordaan C.; Landers G.; Ruff P.; Szpak W.; Tabane N.; Brana I.; Iglesias Docampo L.; Lavernia J.; Mesia R.; Abel E.; Muratidu V.; Nielsen N.; Cristina V.; Rothschild S.; Wang H.-M.; Yang M.-H.; Yeh S.-P.; Yen C.-J.; Soparattanapaisarn N.; Sriuranpong V.; Aksoy S.; Cicin I.; Ekenel M.; Harputluoglu H.; Ozyilkan O.; Harrington K.; Agarwala S.; Ali H.; Alter R.; Anderson D.; Bruce J.; Campbell N.; Conde M.; Deeken J.; Edenfield W.; Feldman L.; Gaughan E.; Goueli B.; Halmos B.; Hegde U.; Hunis B.; Jotte R.; Karnad A.; Khan S.; Laudi N.; Laux D.; Martincic D.; McCune S.; McGaughey D.; Misiukiewicz K.; Mulford D.; Nadler E.; Nunnink J.; Ohr J.; O'Malley M.; Patson B.; Paul D.; Popa E.; Powell S.; Redman R.; Rella V.; Rocha Lima C.; Sivapiragasam A.; Su Y.; Sukari A.; Wong S.; Yilmaz E.; Yorio J. | The Lancet | 1750 | 1531 | |
2018 | Pembrolizumab for the treatment of advanced salivary gland carcinoma | Cohen R.B.; Delord J.-P.; Doi T.; Piha-Paul S.A.; Liu S.V.; Gilbert J.; Algazi A.P.; Damian S.; RUEY-LONG HONG ; Le Tourneau C.; Day D.; Varga A.; Elez E.; Wallmark J.; Saraf S.; Thanigaimani P.; Cheng J.; Keam B. | American Journal of Clinical Oncology: Cancer Clinical Trials | 148 | 119 | |
2023 | Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial | Chan, A T C; Lee, V H F; RUEY-LONG HONG ; Ahn, M-J; Chong, W Q; Kim, S-B; Ho, G F; Caguioa, P B; Ngamphaiboon, N; Ho, C; Aziz, M A S A; Ng, Q S; Yen, C-J; Soparattanapaisarn, N; Ngan, R K-C; Kho, S K; Tiambeng, M L A; Yun, T; Sriuranpong, V; Algazi, A P; Cheng, A; Massarelli, E; Swaby, R F; Saraf, S; Yuan, J; Siu, L L | Annals of oncology : official journal of the European Society for Medical Oncology | 16 | 13 | |
2013 | Pemetrexed in combination with cisplatin versus cisplatin monotherapy in East Asian patients with recurrent or metastatic head and neck cancer: Results of an exploratory subgroup analysis of a phase III trial | Urba S.; RUEY-LONG HONG ; Hossain A.M.; Cheng R.; Orlando M. | Asia-Pacific Journal of Clinical Oncology | 1 | 1 | |
2012 | Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: Final results of a randomized, double-blind, placebo-controlled, phase 3 study | Urba S.; Van Herpen C.M.L.; Sahoo T.P.; Shin D.M.; Licitra L.; Mezei K.; Reuter C.; Hitt R.; Russo F.; Chang S.-C.; Hossain A.M.; Frimodt-Moller B.; Koustenis A.; RUEY-LONG HONG | Cancer | 38 | 30 | |
2023 | A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | Razak, Albiruni R Abdul; Wang, Hung-Ming; Chang, Jang-Yang; Ahn, Myung-Ju; Munster, Pamela; Blumenschein, George; Solomon, Benjamin; Lim, Darren Wan-Teck; RUEY-LONG HONG ; Pfister, David; Saba, Nabil F; Lee, Se-Hoon; van Herpen, Carla; Quadt, Cornelia; Bootle, Douglas; Blumenstein, Lars; Demanse, David; Delord, Jean-Pierre | Targeted oncology | 0 | | |
2001 | Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors: The relation between pharmacokinetic property and toxicity | RUEY-LONG HONG ; Tseng Y.-L. | Cancer | 81 | | |
2012 | A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor | SHIH-HUNG YANG ; CHIA-CHI LIN ; ZHONG-ZHE LIN ; Tseng Y.-L.; RUEY-LONG HONG | Investigational New Drugs | 34 | 28 | |
2003 | A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma | RUEY-LONG HONG ; Tseng Y.-L. | Cancer Chemotherapy and Pharmacology | 41 | 38 | |